2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Postmenopausal: new trials by email Literature Review of Postmenopausal trials Research Report on Postmenopausal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer Biopsy of Breast, Copanlisib, Laboratory Biomarker Analysis - Estrogen Receptor Positive, HER2/Neu Negative | Phase 1 | Terminated | Jonsson Comprehensive Cancer Center | 10 | 2017-08-02 | 2022-09-26 |
| Effects of Denosumab on the Pharmacokinetics of Etanercept Etanercept, Denosumab - Postmenopausal, Osteopenia | Phase 1 | Terminated | Amgen | 19 | 2011-03-01 | 2017-06-20 |
Arthritis (1) · Arthritis, Rheumatoid (1) · Bone Diseases, Metabolic (1) · Breast Neoplasms (1) · Osteoporosis (1)
Skin and Connective Tissue Diseases (2) · Autoimmune Diseases (1) · Bone Diseases (1) · Breast Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Joint Diseases (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Nutritional and Metabolic Diseases (1) · Rheumatic Diseases (1) · Skin Diseases (1)
Denosumab (1) · Etanercept (1) · Letrozole (1) · copanlisib (1) · palbociclib (1)
Amgen (1) · Jonsson Comprehensive Cancer Center (1)
United States (2)
Sara Hurvitz (1)